Common Reasons for Supplementary Information Requests in Overseas Registration of Imaging Equipment

Key Summary

This article explains the most common reasons why overseas registration of imaging equipment triggers requests for supplementary information, including classification errors, incomplete evidence chains, insufficient localization, and ineffective agent collaboration. It provides a structured approach to minimize deficie

Key Summary

Common reasons for supplementary information requests in overseas registration of imaging equipment are concentrated in classification errors, incomplete evidence chains, insufficient localization, and ineffective agent collaboration. Companies often focus only on technical reports while neglecting differences in the target country's medical device regulatory scope, product risk class, and registration pathway. For imaging equipment, every document—intended use description, performance verification, risk management, clinical evaluation, labeling and instructions for use, as well as software and cybersecurity documentation—can trigger a supplementary information request. To reduce deficiencies, companies should conduct a gap analysis early in the project, assess the reusability of existing NMPA, CE, FDA, ISO 13485, and MDSAP documentation, and then perform local adaptation against target country requirements. For registration in GHWP member countries and multi-country filings, greater attention should be given to reusing core technical files and managing country-specific differences, while verifying that the local authorized representative is properly designated and post-market maintenance and update mechanisms are complete. Common risks include: incorrect classification, outdated standard versions, insufficient clinical evidence, inaccurate label translations, risk management misaligned with current standards, and local agents not engaged in technical review. The correct response is not to passively submit additional materials but to establish an evidence chain and checklist covering the entire registration process.

Applicable Scenarios and Core Issues

In overseas registration of imaging equipment, supplementary information requests are almost inevitable for every manufacturer. A request does not mean registration failure; it means the regulatory authority considers the submitted documentation insufficient to demonstrate the product's safety and effectiveness. Companies should understand that a deficiency letter reflects evidence gaps, not a procedural penalty.

For imaging equipment such as X-ray, CT, ultrasound, and MRI, registration documentation typically covers product classification, technical files, performance verification, risk management, clinical evaluation, labeling and instructions for use, local agent, and post-market maintenance. Any module with missing information, inappropriate methods, or inconsistent evidence can lead to a supplementary information request.

The most common reasons for supplementary requests include: incorrect product classification, mismatch between intended use description and clinical evidence, incomplete coverage of essential safety and performance requirements, risk management reports not aligned with the latest standard versions, insufficient software verification documentation, missing cybersecurity requirements, labels and instructions not meeting target country language requirements, irregular local representative authorization documents, and post-market surveillance plans non-compliant with local regulations.

Before preparing overseas registration, companies should first clarify the target country's regulatory framework, determine the product classification and registration pathway, and then assess whether existing NMPA, CE, FDA, or ISO 13485 documentation can be reused. Only by establishing clear registration logic can repeated back-and-forth during the deficiency process be avoided.

For companies conducting multi-country registration in GHWP member states, Southeast Asia, the Middle East, or Latin America, supplementary requests may also arise from localization differences. For example, the same risk management report may be accepted in one country but require specific standard cross-reference tables in another.

Registration Judgment Logic

The underlying reason for frequent supplementary requests is not that companies cannot write documentation, but that they do not organize evidence according to the target country's judgment logic. Companies should complete a top-down, five-step judgment process.

Step 1: Confirm Scope of Medical Device Regulation

Determine whether the product falls within the target country's scope of medical device regulation. Certain imaging equipment accessories, standalone software, or AI-assisted diagnostic functions may be regulated separately. Companies cannot infer based solely on the main device classification.

Step 2: Determine Product Risk Class and Registration Pathway

Different countries have significantly different classification rules for imaging equipment. The same ultrasound device may be Class B in Country A and Class C in Country B, leading to different registration pathways.

Step 3: Assess Reusability of Existing Documentation

NMPA registration files, CE technical documentation, FDA 510(k) submissions, ISO 13485 quality system certificates, and MDSAP audit results are all useful foundations for overseas registration. However, each document must be checked line by line against target country requirements.

Step 4: Verify Technical and Administrative Requirements

Confirm technical files, performance verification, risk management, clinical evaluation or clinical evidence, labeling and instructions, local agent, authorized representative, and post-market maintenance requirements. For example, GHWP member countries generally recognize IMDRF framework documents but may still require localization in language and format.

Step 5: Establish a Collaboration Mechanism with the Local Agent

Many deficiency issues arise during information transmission. The manufacturer may assume the agent has submitted a complete dossier, but the agent's template may not align with target country requirements.

When reusing existing NMPA or CE files, special attention should be paid to version differences, test report dates, and standard updates. An expired EN ISO 14971 report is often a key reason for a supplementary request.

Documentation and Evidence

The core documentation for overseas registration of imaging equipment falls into six categories, each a common area for deficiency requests.

1. Product Basic Information and Classification Basis

Companies must provide device name, model, component list, intended use, target population, environment of use, and a cross-reference to the target country's classification rules.

2. Technical Files and Performance Verification Reports

This includes EMC, electrical safety, mechanical safety, radiation safety, image quality, software functionality, and cybersecurity test reports. These reports must be issued by laboratories compliant with ISO/IEC 17025, and report dates must match the current product version.

3. Risk Management Documentation

Submit a risk management report, risk analysis, risk evaluation, and risk control measures consistent with ISO 14971, and explain whether residual risks are acceptable.

4. Clinical Evaluation or Clinical Evidence

For certain Class II and above imaging devices or software with diagnostic assistance functions, regulatory authorities may require clinical literature, clinical data, or clinical trial reports. Companies cannot simply substitute with predicate device comparisons; equivalence must be demonstrated.

5. Labels, Instructions for Use, and Manuals

The target country language version must cover contraindications, warnings, precautions, disinfection methods, cybersecurity configuration, and other mandatory content.

6. Local Agent and Post-Market Maintenance Documents

This includes authorization letters, agency agreements, registration holder information, adverse event reporting procedures, vigilance systems, product tracking, and update notification requirements.

Companies should create a document index for each product version to ensure consistency among test reports, labels, instructions, and software version. Any inconsistency may be interpreted as weak quality system management.

Common Errors

Based on AIMEILI's observations of overseas deficiency cases, companies involved in imaging equipment registration often make six types of errors. The following checklist can help identify potential issues.

Incorrect product classification, leading to the wrong registration pathway and invalidating all subsequent documentation.
Overstated intended use, for example, writing an imaging software intended only for screening as a diagnostic tool, resulting in insufficient clinical evidence.
Outdated risk management report, not referencing the latest target country standards or guidelines, such as IEC 60601 series updates.
Missing software and cybersecurity documentation, especially for imaging devices supporting AI or remote access, which often require algorithm validation and vulnerability assessment.
Labels and instructions are direct translations rather than localized adaptations, omitting mandatory symbols and precautionary statements.
Insufficient local agent involvement, where the registration strategy is agent-led but technical documents are prepared by the manufacturer, causing misalignment on supplementary requirements.

Companies should note that regulatory authorities review not only technical depth but also internal consistency of the dossier. For example, the product model in performance reports must exactly match labels, instructions, and certificates.

Enterprise Preparation Checklist

To reduce the number of supplementary information requests for overseas imaging equipment registration, the following preparation checklist is recommended before project initiation.

Determine the product classification and registration pathway for each target country and retain written justification.
Review existing technical documents and mark which are reusable, which need updating, and which must be generated anew.
Compare the latest target country technical standards and check performance verification coverage item by item.
Prepare a complete risk management report mapped line-by-line to ISO 14971 requirements.
Build a clinical evaluation file, including search strategy, literature screening, evidence level, and equivalence demonstration.
Arrange localization and medical review of labels and instructions to ensure accurate professional terminology.
Sign local agent agreements with clear authorization scope, change notification obligations, and post-market responsibilities.
Develop a post-market surveillance and adverse event reporting procedure, and assign a specific responsible person.

This checklist is not a one-time task; it should be updated dynamically based on regulatory review feedback. After each supplementary response, categorize the issues and update the internal checklist.

AIMEILI's Perspective

In helping imaging equipment companies with overseas registration, AIMEILI has found that one of the most common misjudgments is assuming that having CE or FDA documentation automatically covers all other countries. In reality, each country has its own regulatory system, technical standards, language requirements, and review priorities.

Early in a project, a gap analysis should be prioritized over direct document writing. The gap analysis should benchmark against the target country's registration requirements, compare existing documentation line by line, and identify which documents can be directly reused, which require additional testing, and which must be locally rewritten.

Technical reports, risk management, EMC, and electrical safety test data for imaging equipment are generally reusable across countries. However, clinical evaluation, instructions for use, labels, and chemical/material information require adjustment based on local population characteristics and regulations. For example, some countries impose additional radiation protection requirements for X-ray equipment.

The local agent's role is not merely to submit files; the agent must act as a technical translator and regulatory advisor during deficiency communications. Companies should ensure they retain control over certificates, and that all changes, renewals, and product updates are synchronized through the agent. This prevents lapses in registration validity due to corporate restructuring or agent replacement.

For multi-country registrations, companies should build a country-difference cross-reference table based on core technical documents. This way, a deficiency issue found in Country A can be checked against Country B and Country C simultaneously, avoiding repeated occurrences of the same issue across different markets.

Common Follow-up Questions

Is there a limit on the number of supplementary information requests? Can it directly lead to registration failure?

Most countries allow one or more rounds of supplementary information during the review phase, with no unified upper limit. However, excessive response cycles extend the total registration timeline. If technical issues remain unresolved for a prolonged period, regulatory authorities may terminate the review in accordance with applicable regulations.

Will the supplementary points for the same imaging device be identical across different countries?

No. Classification rules, technical standards, acceptance of clinical evidence, and language requirements differ by country. For example, some countries classify software as a separate medical device, while others treat software as an integral part of the hardware. Country-specific analysis is required.

After responding, will the entire dossier be re-reviewed?

Generally, regulators conduct targeted review of the supplementary response content, but the review scope may extend to related technical sections. Therefore, companies should not only answer the questions but also check whether associated documents have been updated consistently.

Need a registration pathway assessment?

Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.

Contact AIMEILI